Skip to main content
. 2017 Oct 25;24(5):295–301. doi: 10.3747/co.24.3648

FIGURE 2.

FIGURE 2

Reduction in days from Notice of Compliance date to funding date, based on quantile. The solid line represents the median reduction in days after the establishment of the pan-Canadian Oncology Drug Review, demonstrated at each quantile level of time traditionally taken to make funding decisions for drug submissions. Grey shading represents the 95% confidence interval.